The Mumdipharma restructure appears to be a net benefit to MVP. Only 8 million EU to buyback European rights with all of the market development work done to date.
- Forums
- ASX - By Stock
- MVP
- Ann: Head of Europe Appointed
Ann: Head of Europe Appointed, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MVP (ASX) to my watchlist
|
|||||
Last
45.0¢ |
Change
-0.020(4.26%) |
Mkt cap ! $47.00M |
Open | High | Low | Value | Volume |
46.5¢ | 47.5¢ | 44.5¢ | $140.3K | 300.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1358 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 14999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1358 | 0.445 |
3 | 32500 | 0.440 |
3 | 18753 | 0.430 |
3 | 30240 | 0.420 |
1 | 764 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 14999 | 3 |
0.470 | 61451 | 4 |
0.475 | 18010 | 1 |
0.480 | 1110 | 1 |
0.495 | 6289 | 3 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online